Daily use of extracorporeal CO₂ removal in a critical care unit: indications and results.

ABSTRACT:

Background

While outcome improvement with extracorporeal CO₂ removal (ECCO₂R) is not demonstrated, a strong pathophysiological rational supports its use in the setting of acute respiratory distress syndrome (ARDS) and COPD exacerbation. We aimed to describe our single-center experience of ECCO₂R indications and outcome.

Methods

Patients treated with ECCO₂R in our medial ICU, from March 2014 to November 2017, were retrospectively enrolled. Primary end point was evolution of ventilator settings during the two first days following ECCO₂R start.

Results

Thirty-three patients received ECCO₂R. Seventeen were managed with Hemolung®, 10 with Prismalung®, 4 with ILA®, and 2 with Cardiohelp®. Indications for ECCO

SUBMITTER: Winiszewski H 

PROVIDER: S-EPMC6022441 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature